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Abstract
Background: A water based combination of 0.1% octenidine dihydrochloride and 2% 2 - phenoxyethanol is
registered in many European countries as an antiseptic solution (octenisept®) for topical treatment with high
antimicrobial activity for human use, but octenidine based products have not been registered for veterinary use
yet. The aim of the present study was to investigate whether octenidine dihydrochloride or 2 -phenoxyethanol, the
two main components of this disinfectant, permeate through animal skin in vitro. Therefore, permeation studies
were conducted using Franz-type diffusion cells. 2 ml of the test compound were applied onto 1.77 cm2 split skin
of cats, dogs, cows and horses. To simulate wounded skin, cattle skin was treated with adhesive tapes 100 times,
as well. Up to an incubation time of 28 hours samples of the acceptor chamber were taken and were analysed by
UV-HPLC. Using the method of the external standard, the apparent permeability coefficient, the flux Jmax, and the
recovery were calculated. Furthermore, the residues of both components in the skin samples were determined
after completion of the diffusion experiment.
Results: After 28 hours no octenidine dihydrochloride was found in the receptor chamber of intact skin samples,
while 2.7% of the topical applied octenidine dihydrochloride permeated through barrier disrupted cattle skin. 2 -
phenoxyethanol permeated through all skin samples with the highest permeability in equine, followed by bovine,
canine to feline skin. Furthermore, both components were found in the stratum corneum and the dermis of all split
skin samples with different amounts in the examined species.
Conclusion: For 2-phenoxyethanol the systemic impact of the high absorption rate and a potential toxicological
risk have to be investigated in further studies. Due to its low absorption rates through the skin, octenidine
dihydrochloride is suitable for superficial skin treatment in the examined species.
Background
Antiseptics are used to kill or inactivate microorganisms
after topical administration on the surface of the body,
in body cavities, and on surgically exposed tissues [1]. In
recent years there has been a strongly growing interest
in developing antiseptic drugs with best effectiveness
against microbes and less potential of microbial resis-
tance for both human and veterinary application. Thus,
octenidine dihydrochloride (OCT), an alkanediylbis[pyri-
dine] germicidal agent with structural similiarity to
chlorhexidine and benzalkonium chloride, was designed
as a new antiseptic drug with optimal antiseptic proper-
ties [1,2]: it is stable under exposition to light, tempera-
ture and in the pH range of 1.6-12.2, and its antiseptic
effects are retained in the presence of albumin or mucin
(no protein error) [1,3]. It is effective against yeasts and
fungi [4,5], Gram-negative and -postive bacteria includ-
ing actinomycetes, as well as plaque-forming bacteria
[1,2,4,6-9]. Another good property of OCT is that low-
level exposure of Methicillin-resistant Staphylococcus
aureus (MRSA) does not develop resistance [10]. Today
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OCT it is used in human medicine in some licensed
antiseptic products in several European countries (e.g.
octenisept® with 0.1% OCT and 2% 2-phenoxyethanol
(PH)). Since OCT is an antiseptic drug with low cyto-
toxicity and high microbicidal effects in human medi-
cine [5,11], it represents an auspicious candidate for
antibacterial treatment in veterinary medicine. The anti-
bacterial treatment of skin e.g. before surgery or wound
treatment seems to be one main application of an anti-
septic, but only few information is available about skin
permeability and possible harmful body concentrations.
To assess the suitability of OCT and PH for superficial
disinfection of healthy and wounded skin in animals we
investigated the in vitro percutaneous permeation of
OCT and PH through intact skin of different species
and barrier disrupted cow skin in diffusion cell experi-




Octenisept® was obtained from Schülke & Mayr GmbH,
Norderstedt, Germany. It contained 0.1% OCT and 2%
PH, together with an undisclosed amount of (3-amido-
propyl cocoate)-dimethylammonium acetate, sodium D-
gluconate, glyce-rol 85%, sodium chloride, sodium
hydroxide, and purified water.
Animals
All animals used in the present study died for reasons
not related to this examination. Canine skin was
obtained from animals that died in final experiments at
the Institute of Parasitology, University of Veterinary
Medicine, Foundation, Hannover. Equine and feline skin
was excised from animals that suffered from uncurable
diseases (University of Veterinary Medicine, Foundation,
Hannover), while bovine udder skin was obtained from
animals that died in slaughterhouse under legal require-
ments. Skin samples were obtained from the lateral
abdominal skin, respectively, bovine udder and were
stored for a maximum of 6 months at -20°C until use.
Experimental setup
All studies were conducted according to the OECD-
guideline 428 [13]. After gentle defrosting of the skin,
the hair was clipped off (hair clipper: Wahl GmbH,
Unterkirnach, Germany) and skin samples with a thick-
ness of 500 μm were obtained using a dermatome (Zim-
mer, Freiburg, Germany). The skin samples were
hydrated in phosphate buffered saline (PBS: 1.44 g diso-
dium hydrogenphosphate, 8.0 g sodium chloride, 0.24 g
potassium dihydrogenphosphate and 0.2 g potassium
chloride; pH 7.4) for 30 minutes before use. Visual
examinations were performed to study the skin integrity;
the skin thickness was determined by a micrometer
(Mitutoyo, Neuss, Germany 450-650 nm).
To induce barrier disruption in some bovine skin sam-
ples, the skin surface was treated with tape strips (Tesa,
Beiersdorf, Hamburg, Germany) up to 100 times. The
removal of all stratum corneum layers was ascertained
by histological examination. Permeation experiments
were conducted in Franz-type diffusion-cells (Permgear,
Bethlehem, USA) with an average permeation area of
1.77 cm2. The receptor compartment contained 12 ml
Soerensen phosphate buffer (9.2 g disodium hydrogen-
phosphate, 4.2 g sodium chloride and 2.0 g potassium
dihydrogenphosphate, pH 7.4), which was stirred conti-
nously with a magnetic bar at 500 U/min. Since both
components show low solubilities in Soerensen phos-
phate buffer (< 0.1 mg/ml), sink conditions have been
assumed during the whole experiment. The donor com-
partment was filled with 2 ml octenisept® (1.14 ml/cm2)
and was covered with parafilm®. A water bath provided
a constant temperature of 32°C in each diffusion cell.
Samples were taken from the receptor compartment
(800 μl) at each time point (1 h, 2 h, 3 h, 4 h, 5 h, 6 h,
22 h, 24 h, 26 h, 28 h) and were replaced with 800 μl
Soerensen phosphate buffer.
High-performance liquid-chromatography (HPLC) was
used to analyse the concentration of OCT and PH with
the following HPLC conditions:
autosampler (508, Beckmann), column (LichroCART
125-4, 5 μm, 18 e, 10 cm, Merck), pre-column (Lichro-
CART 4-A, 5 μm, Merck), heater (SpH 99, Spark Hol-
land; 40°C), UV-VIS-detector (168, Beckmann).
The utilised mobile phase consisted of 80% Methanol
and 20% McIlvaine-buffer (20.8 g Citric acid (anhy-
drous) and 0.4 g disodium hydrogenphosphate; pH 2.2)
for OCT detection and 20% Methanol and 80% McIl-
vaine-buffer for PH detection. The detection wave-
lengths were 280 nm for OCT and 270 nm for PH,
respectively. The flow rate was set up at 1.5 ml/minute
with a pressure of ca. 20 mPa. 100 μl of each sample
were injected into the HPLC.
The HPLC analysis was validated for both test sub-
stances in selectivity, linearity, accuracy, precision and
stability. Selectivity was proven for each test substance
in the chromatogram, and linearity was given between
600 and 10,000 ng/ml for OCT and between 400 and
10,000 ng/ml for PH. The accuracy and the precision
were detected by analysis of low quality control stan-
dards (LQS) as well as high quality control standards
(HQS) on three different days. Relative deviations < 20%
(accuracy) and < 10% (precision) were accepted for LQS
and < 15% for HQS (accuracy and precision). Stability
was given for the whole time of the experiment. The
limits of detection (LOD) were 243.1 ng/ml for OCT
and 91.3 ng/ml for PH. The limits of quantification
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(LOQ) were 600 ng/ml for OCT and 400 ng/ml for PH.
Quantitative analysis was based on comparison with the
calibration curve, while the areas under the curve were
analysed using the method of external standards. The
calculation of the drug amount permeated through 1
cm2 skin was calculated from the concentration in the
receptor chamber according to Niedorf et al. (2008) [14]
using an iterative algorithm to recalculate the flux and
the transport, based on the actual concentration differ-
ence between the donor and acceptor compartments for
short time intervals. The algorithm thus yields non-lin-
ear permeated mass per unit area versus time curves
and calculates both the apparent permeability coefficient
(Papp) and the maximum flux (Jmax) after 28 hours.
The amount of OCT and PH in the stratum corneum
and the dermis was determined after completion of the
diffusion experiment. Therefore, the split skin samples
were rinsed with cold water and the skin sheets were
separated according to Kligman and Christophers (1963)
[15]. The following extraction procedure was performed:
Two ml PBS were added to each sample before homo-
genisation for 30 seconds. 20 μl H2SO4 (2 N) and 4 ml
dichlormethane were added and the samples were sha-
ken for 30 minutes. After centrifugation (10 minutes, 4°
C, 10 × g) the lower phase comprising dichlormethane
was transferred into another vial and was evaporated
using compressed air. 0.5 ml eluent was used to dissolve
the analytes. The recovery was approximately 90-95%.
Results
OCT was not detectable in the acceptor medium of the
histologically intact skin of any examined species during
the experiment (Figure 1), although OCT was found in
the stratum corneum and the dermis of all examined
split skin samples (Table 1). After 6 hours 2.34% and
after 28 hours 2.64% of the applied OCT (2 mg) was
determined in the acceptor fluid of barrier disrupted
bovine skin (Figure 1). PH permeated through all skin
samples (Figure 2), with the highest flux in equine skin
followed by bovine udder skin, canine to feline skin.
After barrier disruption in bovine udder skin a 1.8-fold
higher flux Jmax was observed. After 6 hours the recov-
eries in the receptor compartment ranged from 5.9%
(dog) to 28.4% (horse), while after 28 hours 35.1% (cat)
to 61.1% (horse) were found. All data obtained in the
diffusion experiments are shown in Table 2 and 3. The
amount of PH storage in the skin layers is listed in
Table 1.
Discussion
This study provides information about percutaneous
permeation of OCT and PH out of a licensed superficial
disinfectant through skin of different animals in vitro
and the distribution of both substances in the stratum
corneum and the dermis after 28 hours diffusion experi-
ment. Both components are used for topical surface
treatment and are supposed to stay on the body surface
or within the outmost skin layers to show best effective-
ness against bacteria and other microorganisms. Due to
its high molecular weight (550.9 g/mol) OCT should be
retarded by the outermost skin layer, the stratum cor-
neum. Thus, silimar to porcine skin [12] OCT is not
detectable in the receptor fluid of histologically intact
skin of cats, dogs, cows and horses out of a commonly
available formulation containing 0.1% OCT and 2% PH
after 28 hours under occlusive conditions, although it is
present in the extracts from the stratum corneum and
the dermal skin layers of all animals. The reason for
OCT measurement in the dermis may be due to the fact
that hair follicles arise from the dermis and represent
storage compartments for several drugs [16]. Thus, it is
likely that the amount of OCT measured in the dermal
layers represents the capacity of substance storage in the
hair follicles with considerable differences between the
species depending on the amount and size of the hair
orifices. Therefore, it can be assumed that topically
applied OCT reaches the base of the hair follicles and
affects microorganisms within this hideaway. To study
the effect of stratum corneum disruption in damaged
skin the tape stripping procedure, an experimental setup
suitable for skin with low hair density [17-20], was used
in bovine udder skin. But even after barrier disruption,
only low amounts of OCT were found in the receptor
compartment of bovine skin (2.64% after 28 hours),
which has also been demonstrated for barrier disrupted
porcine skin [12]. It is likely that OCT which reaches
the dermis in barrier disrupted skin samples attaches to
dermal surface structures, since OCT contains four ter-
tiary amino groups, two of which are protonated, and
Figure 1 Permeation rate of OCT. Permeation rate curve of OCT
obtained in diffusion experiments over 28 hours with barrier
disrupted cattle skin (mean and standard deviation); no OCT was
detected after 28 hours in histologically intact skin of cats, dogs,
cattle and horses; (n = 6).
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shows a high affinity to negatively charged surfaces [1].
Thus, the amount of OCT found in the receptor com-
partment of barrier disrupted skin samples is quite mod-
erate, despite stratum corneum removal.
PH, the other constituent of the used disinfectant
combination, was found in all receptor samples with
recoveries of 5.9% (dog) to 28.4% (horse) after 6 hours
to 35.1% (cat) to 61.1% (horse) after 28 hours, whereas
porcine skin, which is comparable to human skin
regarding permeability, exhibits recoveries of only 1.4%
after 6 hours to 11.3% after 28 hours [12]. Interspecies
differences in the permeation rates may be due to skin
characteristics like morphology and lipid composition or
the interaction of the formulation with the different skin
types [21-23]. Similar to Bronaugh et al. (1986) [24] per-
meation differences caused by different storage times
could be ruled out for PH (data not shown), although it
has been demonstrated that freezing increases skin per-
meability e.g. for hydrocortisone through canine full
thickness skin [25]. It is likely, that an enhancing effect
of freezing on PH permeability was not detectable, since
PH permeates relatively quickly through intact animal
skin out of the examined formulation and significant
increases in permeability may thus be harder to be
found. High in vitro permeability rates of PH have also
been observed for rat and human skin. Roper et al.
(1997) showed that depending on the receptor fluid
used in the diffusion cell experiment 43-64% PH perme-
ated within 28 hours, while occlusive dressing led to
99% permeability [26]. It has also been described to be
readily absorbed by newborn’s skin with extensive oxida-
tive metabolisation to 2-phenoxyacetic acid [27]. How-
ever, first-pass metabolism of PH was not detectable in
our study with skin samples, all of which stored in the
freezer, or during percutaneous permeation through
viable rat and human skin in vitro [20].
The fact that skin damage caused by tape stripping
procedure resulted in a moderate 1.8-fold higher flux of
PH through bovine skin in comparison to a 10.2-fold
higher flux through porcine skin [12] leads to conclu-
sion that the stratum corneum in porcine skin maintains
a stronger permeation barrier than in bovine udder skin,
which has also been demonstrated for several non-ster-
oidal anti-inflammatory drugs [28], all of which exhib-
ited an inverse correlation of permeation with stratum
corneum thickness. Therefore, porcine skin with consid-
erable retention of PH by the stratum corneum is stron-
ger affected by removal of the horny layer than bovine







Mean STD Mean STD Mean STD Mean STD Mean STD
Stratum corneum 1.00 0.28 — — 0.65 0.34 1.79 0.32 0.99 0.57
OCT Dermis 3.36 1.81 5.10 1.15 2.79 0.94 4.67 1.61 2.58 1.01
Total amount 4.37 1.84 3.44 0.99 6.46 1.76 3.57 1.37
Stratum corneum 317.04 66.67 — — 40.94 14.11 82.25 16.41 345.70 126.99
PH Dermis 108.93 20.33 197.08 85.43 79.01 40.28 124.97 55.55 111.67 32.98
Total amount 407.81 67.65 113.13 44.90 207.21 59.70 457.37 144.67
Amount of OCT and PH in the stratum corneum and the dermis of the split skin samples after 28 hours experiments (n = 4-6)
Figure 2 Permeation rates of PH. Permeation rate curve of PH obtained in diffusion experiments over 28 hours with histologically intact skin
samples (left) and barrier disrupted cattle skin (right) (mean and standard deviation); (n = 6).
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skin, which already exhibits high permeation rates in
physiologically intact skin.
Conclusion
After topical treatment of healthy animal skin with a
combination of OCT and PH just PH permeates
through the skin, while OCT permeates the skin only in
small amounts after barrier damage. The systemic
impact of the high absorption rate of PH and a potential
toxicological risk have to be investigated in further stu-
dies or should lead to conclusion to avoid PH in disin-
fectants used for topical treatment of the investigated
species. In contrast, the low absorption rates of OCT
demonstrate its suitability for topical disinfection.
Taking into account the good efficacy of OCT against
a wide range of micro-organisms, it represents a promis-
ing antibacterial agent for superficial skin treatment in
animals.
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